The aim of the study is to evaluate the beneficial effect of a probiotic preparation with an antiinflammatory and modulating activity on immunological processes, with positive results on different inflammatory and atopic conditions.
In this study the investigators evaluate the safety and efficacy of a probiotic formulation in the reduction of symptoms and use of topic and systemic corticosteroids and antihistamines in the treatment of mild atopic dermatitis according to Hanifin and Rajka diagnostic criteria for atopic dermatitis, with a SCORAD (Scoring Atopic Dermatitis) index of 20 to 40, in patients 4 to 18 years old, that require the use of said drugs due to disease flare-ups, and to whom the usage of topic corticoids to control said flare-ups is indicated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
51
Centro Dermatologico Estetico de Alicante
Alicante, Alicante, Spain
Time of use of topic corticosteroids
Duration of treatment with topic corticosteroids
Time frame: twelve weeks
Variation in SCORAD score during treatment
Time frame: twelve weeks
Variation in the Global Clinical Impression (CGI) score during treatment
Time frame: twelve weeks
Exposure to other treatments
Duration of treatment with systemic corticosteroids or antihistamine drugs
Time frame: twelve weeks
side effects due to treatment in two arms of treatment
Number of side effects due to probiotic and due to placebo
Time frame: twelve weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.